The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection

Human respiratory syncytial virus (hRSV) transmission dynamics are inherently cyclical, and the observed genetic diversity (between groups A and B) also appears to have a repeating pattern. A key unknown is the extent to which genetic variants interact immunologically, and thus impact on epidemiology. We developed a novel mathematical model for hRSV transmission including seasonal forcing of incidence and temporary intra- and inter-group partial immunity. Simultaneous model fits to data from two locations (England & Wales, UK, and Turku, Finland) successfully reproduced the contrasting infection dynamics and group A/B dominance patterns. Parameter estimates are consistent with direct estimates. Differences in the magnitude and seasonal variation in contact rate between the two populations alone could account for the variation in dynamics between these populations. The A/B group dominance patterns are explained by reductions in susceptibility to and infectiousness of secondary homologous and heterologous infections. The consequences of the observed dynamic complexity are discussed.

[1]  P. Cane,et al.  Respiratory syncytial virus epidemiology in a birth cohort from Kilifi district, Kenya: infection during the first year of life. , 2004, The Journal of infectious diseases.

[2]  H. Whittle,et al.  Risk factors for severe respiratory syncytial virus infection leading to hospital admission in children in the Western Region of The Gambia. , 1999, International journal of epidemiology.

[3]  W. Press,et al.  Numerical Recipes in C++: The Art of Scientific Computing (2nd edn)1 Numerical Recipes Example Book (C++) (2nd edn)2 Numerical Recipes Multi-Language Code CD ROM with LINUX or UNIX Single-Screen License Revised Version3 , 2003 .

[4]  C B Hall,et al.  Respiratory syncytial virus infections within families. , 1976, The New England journal of medicine.

[5]  R. Chanock,et al.  Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children. , 1961, Journal of the American Medical Association (JAMA).

[6]  E. Norrby,et al.  Two distinct subtypes of human respiratory syncytial virus. , 1985, The Journal of general virology.

[7]  W. Sullender Respiratory syncytial virus genetic and antigenic diversity. , 2000, Clinical microbiology reviews.

[8]  A. M. Collier,et al.  Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. , 1979, The New England journal of medicine.

[9]  A. Osterhaus,et al.  Respiratory syncytial virus specific serum antibodies in infants under six months of age: Limited serological response upon infection , 1997, Journal of medical virology.

[10]  O. Pybus,et al.  Unifying the Epidemiological and Evolutionary Dynamics of Pathogens , 2004, Science.

[11]  J. Sinnott,et al.  Respiratory Syncytial Virus , 1988, Infection Control & Hospital Epidemiology.

[12]  C. Hall,et al.  Respiratory syncytial virus infections in previously healthy working adults. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  M. Waris Pattern of respiratory syncytial virus epidemics in Finland: two-year cycles with alternating prevalence of groups A and B. , 1991, The Journal of infectious diseases.

[14]  Pejman Rohani,et al.  Seasonnally forced disease dynamics explored as switching between attractors , 2001 .

[15]  A. Weber,et al.  Modeling epidemics caused by respiratory syncytial virus (RSV). , 2001, Mathematical biosciences.

[16]  L. White,et al.  Cross immunity and vaccination against multiple microparasite strains. , 1998, IMA journal of mathematics applied in medicine and biology.

[17]  E. Simões Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. , 2003, The Journal of pediatrics.

[18]  J. Quero,et al.  Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons , 2001, The Pediatric infectious disease journal.

[19]  W. P. Glezen,et al.  Risk of primary infection and reinfection with respiratory syncytial virus. , 1986, American journal of diseases of children.

[20]  C. Hall,et al.  Respiratory syncytial virus: concerns and control. , 2003, Pediatrics in review.

[21]  F. A. Seiler,et al.  Numerical Recipes in C: The Art of Scientific Computing , 1989 .

[22]  J. Saiz,et al.  Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique , 2002, Journal of medical virology.

[23]  E. Walsh,et al.  Respiratory Syncytial Virus Infection in Adults , 2000, Clinical Microbiology Reviews.

[24]  Graham F Medley,et al.  On the determinants of population structure in antigenically diverse pathogens , 2002, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[25]  A. McLean Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework , 1995, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[26]  P. Collins,et al.  The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness. , 1988, The Journal of general virology.

[27]  A. Osterhaus,et al.  G Protein Variation in Respiratory Syncytial Virus Group A Does Not Correlate with Clinical Severity , 2000, Journal of Clinical Microbiology.

[28]  J. Kahn,et al.  Correlation between respiratory syncytial virus genotype and severity of illness. , 2002, The Journal of infectious diseases.

[29]  Simon A. Levin,et al.  The dynamics of cocirculating influenza strains conferring partial cross-immunity , 1997, Journal of mathematical biology.

[30]  P. Kaye Infectious diseases of humans: Dynamics and control , 1993 .

[31]  G. Medley,et al.  Dynamics of Multiple Strains of Infectious Agents Coupled by Cross-Immunity: A Comparison of Models , 2002 .

[32]  D. Matthews,et al.  Analysis of respiratory syncytial virus strain variation in successive epidemics in one city , 1994, Journal of clinical microbiology.

[33]  A multispecies model for the transmission and control of mastitis in dairy cows , 2001, Epidemiology and Infection.

[34]  L. Lehtonen,et al.  Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[35]  P. Fine,et al.  Measles in England and Wales--I: An analysis of factors underlying seasonal patterns. , 1982, International journal of epidemiology.